The expectations that companies deal with sustainability risks are increasing. The pressure is also growing in the pharmaceutical industry. At first glance, the highly regulated industry does not need to worry too much in the so-called ESG area. However, controversies are looming, especially when it comes to social criteria.
By Eugenie Ankowitsch
From the war in Ukraine to the global minimum tax and EU reform, the French presidency still has a lot to do after President Emmanuel Macron's re-election. The European agenda is full to the brim – but it is unclear whether Macron will be able to "govern through" as usual until the end of June because the parliamentary elections in his own country will demand a lot of his attention.
By Eric Bonse
Putin's cold-blooded attack on Ukraine has shown that the member states of the European Union have many more common tasks to perform than the EU Treaty currently provides.
By Redaktion Table
